Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Thai Drug Maker Says Second H1N1 Seed Virus Produces Higher Yield

This article was originally published in PharmAsia News

Executive Summary

A Thailand drug maker reports its second batch of seed virus has proved successful in delivering a higher yield of H1N1 flu vaccine. The Government Pharmaceutical Organization's director said the quality of seed virus liquid in the second batch also is better than that of the first. The second batch of seed virus was sought from a foreign supplier after the first provided a yield considered too low to be useful. (Click here for more



Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts